This inventor holds 8 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: University of Copenhagen, Var2 Pharmaceuticals Aps. Active years: 2010-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ishøj, DK (2010)
- Greve, DK (2018 - 2023)
Company Filing History:
Years Active: 2010-2023
Title: Inventor Profile: Thor Grundtvig Theander
Introduction
Thor Grundtvig Theander is a prominent inventor based in Greve, Denmark. He has been awarded a total of seven patents, contributing significantly to the fields of biotechnology and medicine. His innovations are particularly focused on functional binding fragments and virus-like particle vaccines, showcasing his expertise in developing advanced therapeutic solutions.
Latest Patents
Among his latest patents, Theander has developed the following:
1. **Targeting of Chondroitin Sulfate Glycans** - This invention relates to functional binding fragments, including minimal binding fragments of VAR2CSA. It covers antibodies against such binding fragments, nucleic acids encoding these fragments, and methods for their production. The invention also pertains to conjugates and fusion proteins of VAR2CSA polypeptides and their use in treating conditions associated with the expression of chondroitin sulfate A (CSA).
2. **Virus-like Particle with Efficient Epitope Display** - This invention describes a virus-like particle (VLP) based vaccine that presents a non-naturally occurring, ordered, and repetitive antigen array display scaffold. This innovative vaccine is designed to elicit a strong and long-lasting immune response, making it applicable for the prophylaxis and/or treatment of diseases such as cancer, cardiovascular issues, infections, chronic ailments, neurological disorders, asthma, and immune-inflammatory diseases.
Career Highlights
Thor Grundtvig Theander has been affiliated with notable institutions, including the University of Copenhagen, where he conducted research and innovation in the fields of biotechnology and medicine. Additionally, he has worked with Var2 Pharmaceuticals Aps, contributing to advancements in therapeutic strategies against diseases.
Collaborations
Throughout his career, Theander has collaborated with esteemed professionals in his field, including Ali Salanti and Susan Thrane. These partnerships have helped foster innovation and accelerate the development of his groundbreaking inventions.
Conclusion
Thor Grundtvig Theander stands out as a key figure in the realm of biotechnology, with his patents reflecting a deep commitment to addressing significant health challenges. His work continues to influence research and development efforts, making an impactful contribution to the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile